Study S002244

A Prospective Clinical Study to Investigate Dopamine Level Changes in the Brain at Food Cognition by GLP-1 Receptor Agonists

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07732426
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Masking: NONE
Status: RECRUITING
Enrollment: 30
Start: 2026-07-15
Primary completion: 2028-02-29
Lead sponsor: Seoul National University Hospital
Conditions: Food Addiction Tendency; Obesity; Overweight
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in Dopamine Binding Potential During the Look, Smell, and Drink Period [Group A: At Baseline (Day 0) and 8 weeks (±3 days) after starting semaglutide. Group B: At 8 weeks (±3 days) after starting semaglutide and 8 weeks after semaglutide discontinuation.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.